More on ALMKT
News
- Mauna Kea Technologies: Monthly information regarding the total number of voting rights and shares comprising the share capital
- Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts
- Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth
- Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
- Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Col
- Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation
Entities mentioned with ALMKT
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Vanguard | View Related Stories »
- Crude Oil | View Related Stories »
- S1 | View Related Stories »
- JPMorgan | View Related Stories »
- Raising Prices | View Related Stories »
- Show More...
